SEC Form 4 · accession 0001756697-26-000004
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nilda Mesa
Director
Period of report
Sep 14, 2026
Accepted (ET)
Sep 15, 2026 · 4:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2026 | M | 130 | $110.86 | A | 6,560 | D | |
| Common StockF1 | Sep 14, 2026 | S | 130 | $505.7868 | D | 6,430 | D | |
| Common Stock | Sep 14, 2026 | S | 98 | $505.975 | D | 5,580 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $110.86 | Sep 14, 2026 | M | 130 | D | Oct 31, 2019 | Oct 31, 2028 | Common Stock | 130 | 6,430 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $505.76 to $505.985. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.